Compare Neurocrine Biosciences Inc (NBIX) vs Vanguard S&P 500 ETF (VOO) Price & Performance

Neurocrine Biosciences IncTrade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Vanguard S&P 500 ETF — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Vanguard S&P 500 ETF trades at $687.4. Which is the better fit depends on your goals.

	NBIX	VOO
Market Cap	$17.40B	—
Sector	Health	Broad Market / Factor
52-Week High	$180.55	$698.29
52-Week Low	$123.10	$571.45
Enterprise Value	$16.49B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NBIX

Neurocrine Biosciences appoints Samir Siddhanti as Chief Business Officer to lead growth strategy.PRNewsWire · 7 hours agoBullish View details →

VOO

Buy rating maintained on US index assets despite AI sector volatility and bubble concerns.Seeking Alpha · 5 hours agoBullish DIA ETF underperforms S&P 500 ETFs due to higher fees and price-weighted index design.24/7 Wall Street · 3 days agoBearish SPY ETF charges higher fees than its cheaper sibling SPYM with identical S&P 500 exposure.24/7 Wall Street · 4 days agoBearish View details →

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.